Navigation Links
Heska Announces Installation of New Chemistry Analyzer
Date:12/14/2009

LOVELAND, Colo., Dec. 14 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA; "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, today announced the first customer installation of the Company's new DRI-CHEM® 7000 Veterinary Chemistry Analyzer (the "DRI-CHEM® 7000").

(Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO)

Customers receiving these analyzers have invested in the fastest multi-patient clinical chemistry analyzer available to the veterinary in-clinic market. The DRI-CHEM® 7000 analyzer provides the same testing flexibility of the DRI-CHEM® 4000 Veterinary Chemistry Analyzer plus additional advantages such as multiple-patient staging, auto-dilution and a new "STAT" sample feature which provides emergency sample flexibility in critical cases.

"We are pleased to deliver another choice for advanced chemistry analyzers to the veterinary market and believe this latest addition will continue to support our customers' needs for fast and accurate chemistry results," said Robert Grieve, Heska's Chairman and Chief Executive Officer. "Heska's dedicated pursuit to bringing the most advanced diagnostics to the veterinary industry is resolute."

About Heska

Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines. The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future operations. These statements are based on current expectations and are subject to a number of risks and uncertainties. Investors should note that these statements are based on current plans, which may not be fulfilled as expected and may not have the positive impact even if fulfilled as expected. In addition, factors that could affect the business and financial results of Heska generally include the following: uncertainties surrounding recently launched products, including Heska's ability to successfully commercialize such products; risks regarding Heska's ability to successfully market, sell and distribute its products in an economically sustainable manner; competition, including uncertainties regarding the impact of new products competitors have recently launched or may launch in the future; risks regarding Heska's reliance on third-party suppliers, which is substantial and could have significant negative consequences if Heska were to lose exclusive rights or access to a product due to a supplier decision or for other reasons; uncertainties related to the loss of access to products from Abbott Point of Care Inc. after November 1, 2009, which represent approximately 18% of Heska's revenue for the year ended September 30, 2009; uncertainties regarding Heska's reliance on third parties to whom Heska has granted substantial marketing rights to certain of Heska's existing products and whom may be large Heska customers; uncertainties regarding Heska's ability to generate profits and positive cash flow in future periods; uncertainties related to Heska's ability to maintain its listing on the Nasdaq Capital Market; risks related to Heska's reliance on third parties to properly and timely complete certain research and development activities; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Annual Report on Form 10-K for the year ended December 31, 2008 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2009.

SOURCE Heska Corporation


'/>"/>
SOURCE Heska Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Webcast Alert: Heska Announces Second Quarter 2009 Earnings Conference Call Webcast
2. Heska Announces Q109 Results
3. Webcast Alert: Heska Corporations Annual Meeting of Stockholders Webcast
4. Heska Announces Q4 and Annual 2008 Results
5. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast
6. Heska to Present at New York Society of Security Analysts 12th Annual Biotech and Specialty Pharma Conference
7. Heska Announces Q3 2008 Results
8. Webcast Alert: Heska Announces Third Quarter 2008 Earnings Conference Call Webcast
9. Deloitte Names Heska Corporation to Colorado Technology Fast 50
10. Webcast Alert: Heska Announces First Quarter 2008 Earnings Conference Call Webcast
11. Webcast Alert: Heska Corporations Annual Meeting of Stockholders Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... The Georgia State University College of Law new ... Urban Design Commission. , The annual award recognizes projects, programs, individuals and organizations that ... preservation of its physical heritage and the balance between the old and the new. ...
(Date:5/25/2016)... ... 2016 , ... A new update to Xsens popular data analysis ... a common Wi-Fi network and a mobile device. When paired with Xsens MVN or ... and use a mobile device to control the recording. , “The update adds ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... One Florida-based ... potential patients, according to an article published May 13th on Vanity Fair. ... comfortable with having snippets of their procedures broadcast to more than 800,000 Snapchat fans. ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Bank of America Charitable Foundation has awarded ... provide veterans a pathway to employment and successful careers in healthcare. On Wednesday, May ... Hallack, President and CEO of Medisend, parent organization and home of the General Myers ...
(Date:5/25/2016)... ... May 25, 2016 , ... New studies ... of injured workers across 15 states. The outcomes examined in these studies include ... medical care, and satisfaction with medical care. , “The goal of the studies ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Zealand , May 24, 2016 ... informatics solutions for the healthcare sector, has been named the ... Zealand Hi-Tech Awards 2016. Dr Bruce Davey ... acknowledgement for our team.  It,s really good to be recognised ... healthcare internationally. Our products are used in 35 countries around ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
(Date:5/24/2016)... 2016 The innovator of ... , s first dual therapy stent, introduces catheters ... OrbusNeich, a global company specializing in the provision ... include products to treat peripheral artery disease. The JADE™ ... devices for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology: